Introduction
In 1954, Auerbach observed that developmental defects in homozygous Splotch embryos are associated with neural crest cell deficiency. In the homozygous condition the Splotch (Sp) mutation is lethal by embryonic day 13.5. These embryos display defects in neural tissue, neural crest derivatives, and limb musculature. Splotch heterozygotes exhibit defects in neural crest derivatives, which result in white patches on their bellies caused by defective development of neural crest derived melanocytes (Foy et al., 1990) . Chromosome localization in conjunction with the spatio-temporal tissue distribution of Pax3 transcripts and tissues affected in Sp mutants led to direct experimental analysis demonstrating that Splotch and Pax3 are the same gene (Epstein et al., 1991; Goulding et al., 1993) and the homozygous Splotch condition is Pax3 -/-. These studies show that Pax3 has a regulatory role in neural crest development.
Other studies also indicate that Pax3 has a role in regulating neurogenesis in neural crest derived precursor cells. Goulding et al. (1991) demonstrated Pax3 expression in a population of migrating neural crest cells (NCCs) that contribute to the dorsal root ganglia and cephalic mesenchyme. In a separate study Li et al. (1999) found that Pax3 replacement rescued neural tube closure and other neural crest related anomalies in Sp mutants. This group produced transgenic mice that over expressed Pax3 in neural tube and neural crest. They then took Pax3 overexpressing transgenic lines and crossed them with heterozygous Splotch mice. Transgenic heterozygous Splotch mice were identified, backcrossed to Splotch heterozygotes and examined at E13.5. All transgenic Splotch homozygous embryos had normal closed neural tubes in comparison to non-transgenic Splotch homozygous embryos, all of which displayed neural tube defects in the lumbrosacral region and in some cases exencephaly. More recently, our lab (Nakazaki et al., 2008) investigated the mechanism by which Pax3 regulates neurogenesis in neural crest derived precursor cells. We found that Pax3 regulates two bHLH transcription factor genes, Hairy and enhancer of split homolog-1 (Hes1) and Neurogenin2 (Ngn2). Hes1 and other Hes genes prevent premature neurogenesis (Hirata et al., 2001) and Ngn2 plays a critical role in sensory neurogenesis (Lo et al., 2002) . TGFβs are essential for normal neural crest development (Nie et al., 2008) . Loss of TGFβ signaling causes decreased chondrocyte proliferation and premature differentiation of cartilage to bone (Hosokawa et al., 2007) . Expression of Msx2, a critical factor in the formation of the dorso-ventral axis, is diminished in Tgfbr2 mutants (Hosokawa et al., 2007) . The TGFβ intracellular effector Smad3 regulates neuronal differentiation and cell fate specification in the developing spinal cord. Additionally, Smad3 -mediated TGFβ activity promotes neurogenesis, cell-cycle exit and lateral migration of neuroepithelial progenitor cells (García-Campmany and Martí, 2007) . Nie et al. (2008) investigated the role of Smad4, a TGFβ/BMP signaling intermediate, in the development of NCCs. A Cre/loxP system was used to specifically disrupt Smad4 in NCCs. Expression of multiple genes, including Msx1, 2, Pax3 , and Sox9, which play critical roles in NCC development, was down regulated by Smad4 disruption. Mutant mice died at mid-gestation due to severe molecular defects.
TGFβ2-null embryos show open caudal neural tube with unfused spine (Sanford et al., 1997) , similar to Pax3 -/-embryos. Work from our lab established a link between Pax3 and TGFβ2 (Mayanil et al., 2006) . Pax3 regulates the TGFβ2 promoter by binding to its cis-regulatory elements, and TGFβ2 expression is diminished in Pax3 -/-embryos. Thus a regulatory relationship exists between Pax3 and TGFβ2 (Mayanil et al., 2006) .
In the present study we further examined the relationship between Pax3 and TGFβ2 in neural crest development. We found that the open neural tube and bifid spine observed in TGFβ -/-Pax3 +/+ embryos was significantly reversed by down-regulating one allele of Pax3 as in TGFβ2 -/-Pax3 +/-embryos. This reversal may be due to Pax3 and TGFβ2 working together in a regulated fashion to affect the actions of downstream target genes important in neural crest development.
Results
Incidence of neural tube defects in embryos bred from TGFβ β β β β2 +/ -Pax3 +/-double heterozygous mice: phenotypic reversal in TGFβ β β β β2 null embryos by Pax3 down-regulation
In order to investigate how Pax3 and TGFβ interact in neural crest development we first bred TGFβ2 +/-Pax3 +/-double heterozygous mice and examined the phenotypes of resulting offspring. Fig. 1 . E10.0 TGFβ2 -/-Pax3 +/+ and TGFβ2 -/-Pax3 +/-embryos did not exhibit additional external abnormalities. However Sanford et al.,1997) have shown that TGFβ2 null mice exhibit perinatal mortality and a wide range of developmental defects. These include cardiac, lung, craniofacial, limb, spinal column, eye, inner ear and urogenital defects. The developmental processes commonly involved in the affected tissues include epithelial-mesenchymal interactions, cell growth, extracellular matrix production and tissue remodeling. In addition, many affected tissues have neural crest-derived components and simulate neural crest deficiencies (Sanford et al., 1997) .
In the type of study done here there is a possibility of a partial rescue of the TGFβ2 null phenotype due to a mixed genetic A B C (Fode et al., 1998) . Additionally, down-regulation of Hes1 expression, which induces neural progenitor differentiation, leads to sustained up-regulation of Ngn2 (Shimojo et al., 2008) . Sox9 was chosen because it regulates neural crest development (Cheung and Briscoe, 2003) , and it is up-regulated by TGFβ (Zavadil et al., 2001 ) and down-regulated by Pax3 over-expression (Mayanil et al., 2001) . Whole mount in situ hybridization was done on E10.0 (30 somite stage) embryos, using digoxigenin labeled Hes1 ( Fig. 2A) , Ngn2 (Fig. 2B ) and Sox9 riboprobes (Fig. 2C ). Wild type (TGFβ2 +/ + Pax3 +/+ ) embryos expressed Hes1 in dorsal neural tube (red arrow) and in migrating neural crest cells (yellow arrows) (Fig.   2Ai ). Semi-quantification (Fig. 3 ) of our in situ hybridization results with densitometry (total density 8 bit gray) showed a slight but insignificant increase in Hes1 levels in TGFβ2 -/-Pax3 +/+ embryos in both the dorsal neural tube and migrating neural crest cells ( Fig.  2A -ii) as compared with wild type embryos ( Fig. 2A-i) . Hes1 expression was down-regulated in both expression domains in TGFβ2 +/+ Pax3 -/-(* p<0.001) ( Fig. 2A-iii) and in TGFβ2 ++ Pax3 +/-(** p<0.0005) embryos ( Fig. 2A-iv) . Expression was close to wildtype in TGFβ2 +/-Pax3 +/-( Fig. 2A-v) , and TGFβ2 -/-Pax3 +/-embryos ( Fig. 2A-vi) . These studies suggest that both Pax3 and TGFβ2 play a role in regulating Hes1 expression in the dorsal neural tube and migrating NCCs during embryonic development. In situ hybridization experiments for each genotype were done in quadruplicate, representative data is shown here. In situ hybridization using digoxigenin-labeled sense Hes1, Ngn2 and Sox9 riboprobes did not show staining (data not shown). 
Hes1, Ngn2 and Sox9 expression levels in vivo
Based on the above observations and earlier work from our laboratory showing Pax3 regulation of TGFβ2 in migrating NCCs (Mayanil et al., 2006) we surmised that Pax3 and TGFβ2 regulated common effecter genes involved in neural crest development. The significant reversal from the open neural tube phenotype seen in TGFβ2 -/-Pax3 +/+ embryos to closed neural tubes seen in TGFβ2 -/-Pax3 +/-embryos suggested a possible interplay between Pax3 and TGFβ2, where these two may act in a reciprocal fashion to maintain levels of some common downstream genes in proper balance.
To begin elucidating the relationship between Pax3 and TGFβ2 we investigated Hes1, Ngn2 and Sox9 expression levels in embryos with the following 6 genotypes: TGFβ2 +/+ Pax3 +/+ , TGFβ2 -/-Pax3 +/+ , TGFβ2 +/ + Pax3 -/-, TGFβ2 +/+ Pax3 +/-, TGFβ2 +/-Pax3 +/-and TGFβ2 -/-Pax3 +/-. We choose Hes1 and Ngn2 because these molecules are critical in neurogenesis and Pax3 regulates Hes1 and Ngn2 by directly binding to cis-regulatory elements on their promoters (Nakazaki et al., 2008) . Moreover, Hes1 is down-regulated by TGFβ (Zavadil et al., 2001; Blokzijl et al., 2003) and its expression oscillates with 2 hour periodicity during development (Hirata et al., 2002) . Ngn2 expression is coincident with Pax3 during neural tube closure and Ngn2 knockout embryos display neural tube defects
In situ hybridization ( regulated by Pax3 and TGFβ2 during embryonic development.
TGFβ β β β β2 effect on Pax3 regulation of Hes1, Ngn2 and Sox9 promoter activity The TGFβ2 intracellular effector phospho-Smad3 regulates neuronal differentiation and cell fate specification in the developing spinal cord (García-Campmany and Martí, 2007) . To further examine the relationship between Pax3 and TGFβ2 we co-transfected DAOY cells with pcDNA3 or pcDNA3-Pax3 expression constructs, Hes1-luciferase (Fig. 4 A,B) , Ngn2-luciferase (Fig. 5 A,B) or Sox9-luciferase (Fig. 6 A,B) promoter constructs, and Flag-Smad3 or Flag-DN-Smad3 (dominant negative Smad3) expression vectors. Transfected cells were then untreated or treated with 10ng/ml human recombinant TGFβ2 (10 ng/ml) for 6 hours. Luciferase activity was measured 48 hours after transfection.
Hes1-promoter-luciferase and mutant constructs are fully described in our previous paper (Nakazaki et al., 2008) . When pGL3 control vector, Hes-1-luc, Hes1 mut #1 or Hes1 mut #2 constructs were co-transfected with pcDNA3 in DAOY cells, neither Smad3 nor TGFβ2 affected promoter activity (Fig. 4A) . When Hes1-luc was co-transfected with pcDNA3-Pax3, with DN-Smad3 minus TGFβ2, there was a 7-8 fold increase in Hes1 promoter activity in comparison to pcDNA3 transfection (Fig. 4B) . Promoter activity did not increase significantly when Hes1 mut1 or Hes1 mut2 were co-transfected with pcDNA3-Pax3. These results agree with our previous work (Nakazaki et al., 2008) . Pax3 mediated Hes1 promoter activity (DN-Smad3 minus TGFβ2) decreased significantly (p<0.05) in the presence of Smad3 and TGFβ2. Smad3 alone or TGFβ2 and DN-Smad3 did not decrease the Pax3 Fig. 4 (Left) . Effect of Pax3 and TGFβ β β β β2 on Hes1-promoter luciferase activity. DAOY cells were co-transfected with (A) pcDNA3 or (B) pcDNA3-Pax3 construct, Hes1-promoter-luciferase or mutant constructs and wild type Flag-Smad3 or dominant negative Flag DN-Smad3. pGL3 served as a control vector. Transfected cells were treated or not treated with TGFβ, and luciferase activity was measured. Renilla luciferase (pRL-null) was used as a transfection control and luciferase activities are expressed as a ratio of Firefly/Renilla luciferase. Each experiment was done in quadruplicate, with each data point in triplicate. Promoter activity in the presence of Smad3 plusTGFβ2 was compared with activity in the presence of DN-Smad3 minus TGFβ2, significance was determined with the Student T test (*p<0.05). Promoter activity in the presence of Smad3 plusTGFβ2 was compared with activity in the presence of DN-Smad3 minus TGFβ2, significance was determined with the Student T test (**p<0.001; ***p<0.0001). Firefly/Renilla Luciferase Ratio *** B A mediated increase in Hes1 promoter activity. These observations suggest that Hes1 promoter activity is itself not affected by TGFβ2, but TGFβ2 decreases Pax3 induced Hes1 activity. Ngn2-promoter-luciferase and mutant constructs are fully described in our previous paper (Nakazaki et al., 2008) . When pGL3 control vector, FLNgn2-luc (1.2 kb), mut1, mut2, mut4, mut5, mut5 ∆ gttcc constructs were co-transfected with pcDNA3 in DAOY cells, neither Smad3 nor TGFβ2 affected promoter activity (Fig. 5A) . When FLNgn2-luc was co-transfected with pcDNA3-Pax3, with DN-Smad3 minus TGFβ2, there was a 2 fold increase in promoter activity (Fig. 5B ). Pax3 mediated promoter activity was also observed with mut1 (5 fold increase), mut2 (11-12 fold increase) and mut5 (12-14 fold increase) in the presence of DNSmad3 minus TGFβ2. These results agree with our previous work (Nakazaki et al., 2008) . In the presence of Smad3 plus TGFβ2, Pax3 mediated promoter activity was decreased in FLNgn2-luc, mut1 (*p<0.05), mut2 (**p<0.001) and mut5 (**p<0.001). Smad3 alone or TGFβ2 with DN-Smad3 did not decrease Pax3 mediated Ngn2 promoter activity. These observations suggest that Ngn2 promoter activity is itself not affected by TGFβ2, but TGFβ2 decreases Pax3 induced Ngn2 activity.
Sox9-luciferase constructs are described in Kanai and Koopman (1999) . When pGL.b-luc (control vector), pGL/5.2-luc, pE4.0-luc, pE2.4-luc, pSc-luc, pNh-luc and pSm-luc Sox9 promoter constructs were co-transfected with pcDNA3 (Fig. 6A) , there was a significant (p<0.0001) ~ 40 fold increase in Sox9 promoter activity with pSc-luc, minimal essential promoter. This increase was not seen with the other three treatment conditions. When Sox9 promoter constructs were co-transfected with pcDNA3-Pax3 (Fig.  6B) , with DN-Smad3 minus TGFβ2, pE2.4-luc, pSc-luc, and pNhluc constructs showed an insignificant increase in promoter activity in comparison to the vector control, suggesting that Pax3 does not have a direct effect on Sox9 promoter activity. Sox9 promoter may be regulated by genes downstream to Pax3 or coregulators may be required for Sox9 promoter regulation. pSc-luc Sox9 promoter activity increased ~12 fold (p<0.001) as opposed to ~40 fold when co-transfected with pcDNA3 under the same experimental conditions (Smad3 plus TGFβ2). These studies suggest that although the minimum essential Sox9 promoter is not directly regulated by Pax3, it is directly up-regulated by Smad3 plus TGFβ2. Pax3 may negatively affect this increase.
The data presented in this section suggest Pax3 and TGFβ2 may reciprocally regulate Hes1, Ngn2 and Sox9 promoters during development. These downstream effector genes together with Pax3 and TGFβ2 may be part of a coordinated gene regulatory network present during neural crest development. (Fig. 7) . Not all genes will be regulated by these molecules in an opposing fashion, as we did not observe a 100% phenotypic recovery of the open neural tube defect in E10.0 TGFβ2 -/-Pax3 +/-embryos and no phenotypic recovery in TGFβ2 +/ -Pax3 -/-embryos.
Previous data from our lab on Pax3 regulation of genes (Mayanil et al., 2001) and TGFβ regulation of genes from Zavadil et al. (2001) supports the fact that these two developmental regulators may act on certain genes in an opposing fashion. Table  2 shows genes that are up-regulated by Pax3 and down-regulated by TGFβ2, or vice versa. Genes selected for this table from the Mayanil et al. (2001) paper showed at least a 2-fold change in response to Pax3 over-expression in DAOY cells as measured by microarray analysis. In the paper by Zavadil et al. (2001) HaCaT keratinocytes were treated for 2 to 4 hours with TGFβ and gene levels were determined by microarray analysis. Only candidate genes that appear to be regulated in an opposing fashion are shown. Interestingly, Sox4, Sox9 (Hong and Saint-Jeannet, 2005) and type IV collagen (Duband and Thiery, 1987) , are involved in neural crest development and Rho GDP-dissociation inhibitor (RhoGDI) (Maddala et al., 2008) and tissue inhibitor of matrix metalloprotease 3 (TIMP3) (DeBecker et al., 2007) are involved in cell migration.
Role of a Pax3/TGFβ β β β β2 Gene Regulatory Network in neural tube development During early embryonic development Pax3 ensures that NCCs do not execute a differentiation program inappropriate for their dorso-ventral position in the neural tube (Goulding and Lamar, 2000) . Previous work from our lab (Nakazaki et al., 2008) has shown that Pax3 regulates Hes1 which regulates neural stem cell maintenance and Ngn2 which is involved in neural crest cell neurogenesis (Theriault et al., 2005) . Regulation of these molecules may be part of the mechanism by which Pax3 initially maintains neural crest cells in an undifferentiated state prior to migration, and then ensures that positional information is integrated into the neurogenesis process and to the specification of progenitor-cell identity.
Pax3 also regulates TGFβ2 (Mayanil et al., 2006) , which in turn decreases Pax3 increased Hes1 and Ngn2 promoter activity. These observations suggest that a coordinated gene regulatory network between Pax3 and TGFβ2 could play a role in proper timing of neural tube closure and NCC migration. For instance, in the early stages of epithelial to mesenchymal transition (EMT) it may be critical to inhibit Hes1 and Ngn2 without inhibiting Pax3. If Ngn2 is not inhibited during early stages of EMT, migratory NCCs may undergo premature sensory neurogenesis and die prior to reaching their destination (Nakazaki et al., 2008) . Our data suggests that TGFβ2 may be an important player in downregulating Ngn2 in the early stages of EMT.
Recently, Shimojo et al. (2008) have shown a complex interaction between Hes1 and Ngn2. This group found that Hes1 expression dynamically oscillates in neural progenitors. They also found that Hes1 oscillations regulate Ngn2 oscillations. Down-regulation of Hes1 expression, which induces neural progenitor differentiation, leads to sustained up-regulation of Ngn2. Our results also suggest a complex relation between Hes1 and Ngn2, with Pax3 and TGFβ2 playing a role in appropriately timing the expression of these two molecules in NCCs.
Sox9 regulation by Pax3 and TGFβ2 was also examined in this paper. Sox9 has a central role in neural crest formation and subsequent EMT and is required for trunk neural crest survival (Sakai et al., 2006) . Expression of multiple genes, including Pax3 and Sox9, was downregulated by disrupting Smad4 in NCCs, thus providing evidence that Smad4-mediated activities of TGFβ signals are essential for appropriate NCC development (Nie et al., 2008) . Our results indicate that Pax3 does not directly affect Sox9 activity. However, Pax3 may regulate TGFβ effects on Sox9 promoter activity. This interaction may play a role in appropriately timing Sox9 expression in NCCs.
Up-regulation of specific genes and delay in others is expected of a cell that is committed to migration. These events prepare the extracellular matrix (ECM) as well as intracellular cytoskeletal elements for efficient migration. Pax3 and TGFβ2 may also interact in altering levels of various ECM molecules. In a previous study Mayanil et al. (2000) found that Pax3 over-expression upregulated α-2, 8-polysialyltransferase (STX), thereby increasing NCAM polysialylation (PSA-NCAM). PSA-NCAM prefers the migration permissive substrate heparin sulfate proteoglycan, whereas Versican, a large chondroitin sulfate proteoglycan (CSPG2), is a migration non-permissive substrate and promotes NCAM-NCAMmediated homophilic adhesion (Mayanil et al., 2000; Storms and Rutishauser, 1998) . Migration of NCCs during early embryonic development would be facilitated if non-permissive substrates were down-regulated. Henderson et al. (1997) observed Versican overexpression in Pax3 -/-mice, which exhibit defective NCC migration, and suggested that Pax3 may negatively regulate Versican expression. It is likely that extracellular matrix compo- 
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REGULATION OF COMMON DOWNSTREAM GENES BY PAX3 AND TGFΒ Β Β Β Β2
Evaluation of data from Mayanil et al. (2001) and Zavadil et al. (2001) , indicate that TGFβ negatively regulates certain Pax3 downstream genes.
nents such as Versican V3 are regulated by TGFβ2, given the fact that several extracellular components that affect cellmatrix interactions are remodeled by TGFβ for efficient EMT (Zavadil et al., 2001 ). An unpublished observation from our lab shows that Pax3 down-regulation of Versican V3 (Mayanil et al., 2001 ) is partially reversed by TGFβ2 treatment. A final point in relation to extracellular matrix components is that they could play a key role in making mature TGFβ available at an appropriate time to induce EMT by negatively regulating Pax3 downstream genes which keep NCCs in a non-migratory state. ECM components and membrane bound forms of TGFβ co-receptors determine bioavailability of TGFβ to NCCs (Dijke and Arthur, 2007) . Thus TGFβ2 may be secreted by NCCs, but may not be accessible to interact with its receptors on the membrane because of covalent association with the ECM via latent TGFβ-binding protein (LTBP) (Mangasser-Stephan and Gressner, 1999) . However at the critical time, ECM bound large latent TGFβ complex may be released by matrix metalloproteinases. The released complex may be targeted to the cell surface, and proteolytically activated. Interestingly the expression of tissue inhibitor of matrix metalloprotease 3 (TIMP3), which assists in EMT, is increased by Pax3 overexpression and decreased by TGFβ treatment (Table 2) .
In this paper we have begun to examine the regulatory interaction between Pax3 and TGFβ2. Pax3 and TGFβ2 may act as a gene regulatory network in neural tube development and NCC migration. The role of this type of network is to a specify sets of genes that must be expressed in specific spatiotemporal patterns (Meulemans and Bronner-Fraser, 2004) . This regulatory network, in turn, is most likely a small part of a larger network involved in the highly complex behavior of neural crest cells. Fig. 8 is an adaptation of a diagram from Lee et al. (2002) . We have modified this diagram based on published data to show different types of networks that may exist in developing NCCs. Each of these regulatory motifs in turn, may be building blocks that can be combined into larger network structures.
Further work needs to be done to elucidate the complex relationship between Pax3 and TGFβ2 in regulating gene expression levels in NCCs. Regulation of genes downstream of Pax3 and TGFβ2 will involve binding of transcription factors, histones, and other transcriptional regulators to the gene's regulatory region. The regulatory region may serve as an integration point, performing a logical computation of transcription factors to determine resulting gene expression levels (Siggia, 2005) . Transcriptional regulatory proteins, which recruit and regulate chromatin modifying complexes and components of the transcription apparatus, will recognize specific promoter sequences and in turn affect gene expression programs. For instance, Blumenberg et al. (2007) reported that TGFβ-directed EMT is accompanied by chromatin structure regulation involving Polycomb group epigenetic silencers and histone-lysine methyl transferase EZH1 and EZH2. To add to the complexity, Zavadil et al. (2007) reported TGFβ-directed (Tajbakhsh et al., 1997) and MyoD regulating Slug (Zhao et al., 2002) . Pax3 also regulating Slug (Monsoro-Burq et al., 2005) . (C) Multi-component loop: Slug regulating Sox9 and Sox9 regulating Slug (Meulemans and Bronner-Fraser, 2004) 
. (D)
Single input: Slug regulating expression levels of Sox9, Sox10 and FoxD3 (Meulemans and Bronner-Fraser, 2004) . (E) Multi-input: seen in neural crest stem cell specifiers: Pax3 and Sox10 regulate c-ret (Lang and Epstein, 2003) and Mitf (Lang et al., 2005) . Zic1 and Pax3 regulate Foxd3 and Slug (Meulemans and Bronner-Fraser, 2004) , and Smad3 and NICD regulate Hes1 (Blokzijl et al., 2003) . (F) Regulatory chain: Tead2 regulating Pax3 (Milewski et al., 2004) , Pax3 regulating MyoD among others (Tajbakhsh et al., 1997) ; MyoD regulating Slug and Calpain 6 (Zhao et al., 2002) . Additionally, a regulatory network based on TGFβ2 regulation of Slug (Romano and Runyan, 2000) can be constructed by overlapping some of the motifs depicted here. 
Materials and Methods
Double heterozygous mouse breeding and genotyping
The C57BL/6J-Pax3 Sp /J (stock = 2469) male and C57BL/6J breeding pairs were obtained from The Jackson Laboratory. Genotyping of Pax3 +/+ (wild-type), Pax3 +/-heterozygous, and Pax3 -/-homozygous embryos was performed on isolated genomic DNA from embryonic membranes using PCR with a Pax3 +/+ (wild-type) or (Pax3 -/-) homozygous specific reverse primer and a common forward primer in separate PCRs as described by Epstein et al. (1996) . TGFβ2 heterozygous and homozygous genotypes were detected with PCR using the exon 6 primers, p5 (AATGTGCAGGATAATTGCTGC) and p3 (AACTCCATAGATATGGGGATGC). The amplification conditions were 35 cycles at 94°C for 30 seconds, 57°C for 30 seconds and 72°C for 90 seconds (Sanford et al., 1997) . TGFβ2 heterozygous breeding pairs were kindly provided by Dr. T. Doetschman (Sanford et al., 1997) and were used to maintain the TGFβ2 heterozygous colony and to obtain TGFβ2 nullizygous embryos. Double heterozygous males and females were produced by mating TGFβ2 +/-heterozygous females with Pax3 +/-heterozygous males. The double heterozygous males and females were back-crossed with wild type Swiss black females and males respectively for 6 generations. The resulting double heterozygous males and females were than used to generate the TGFβ2 -/-Pax3 +/-genotypes and other genotypes as per Mendelian projection.
Whole mount in situ hybridization
Whole mount in situ hybridization was done as described earlier (Mayanil et al., 2006) . Washes were performed at 65°C. The antisense digoxigenin labeled mouse Hes1 riboprobe was created by linearizing with EcoR1 and synthesized using T7 polymerase. The Hes1 sense riboprobe was made by, linearizing with BamH1 and synthesized using T3 polymerase. The antisense digoxigenin labeled mouse Ngn2 riboprobe was created by linearizing with BamH1 and synthesized using T7 polymerase, the Ngn2 sense probe was made by linearizing with EcoR1 and synthesized using SP6 polymerase. The antisense digoxigenin labeled mouse Sox9 riboprobe was created by linearizing with Hind III and synthesized using T7 polymerase. The Sox9 sense riboprobe was made by linearizing with EcoR1 and synthesized using T3 polymerase. Embryos were stained and photographed with a Spot Camera (Diagnostic Instruments Inc.).
Densitometry was performed on appropriate stained areas, using the Open Lab program (Leica). Areas examined were the dorsal neural tube andÄmigratory neural crest cells in Hes1 riboprobe stained embryos, dorsal and ventral tube regions in Ngn2 riboprobe stained embryos and migratory NCCs in Sox9 riboprobe stained embryos. Staining was quantified from the thoracic/lumbar area downward to include the entire caudal region. On an average, 14-15 somites were counted per embryo of a given genotype. Total density was determined from images scanned in 256 gray scale. The data is represented as the total density (8 bit gray), which is defined as the area multiplied by the mean of the relative densitometry units in the field under investigation. Total density of stained NCCs or dorsal or ventral regions of the neural tube were measured, and then the total density of each genotype was averaged. The data is expressed as average density of all embryos (+/ -SEM) in each genotype category (n= 4 per genotype). Differences between wild type embryos and embryos with other genotypes were compared by subjecting the data to unpaired T-Test with two-tailed P value (Graph Pad PRISM 4). The data is expressed as the average density of all embryos (n=4 per genotype).
Analysis of Hes1, Ngn2 and Sox9 promoter activity in the presence and absence of TGFβ β β β β2
Constructs were kindly provided by: Hes1-promoter luciferase construct, Dr. R. Kageyama, Ngn2-promoter (AF303001) promoter luciferase constructs, Dr. J. Johnson, Sox9-promoter luciferase constructs Dr. P. Koopman. Hes1-and Ngn2-luciferase and their mutant constructs are fully described in our earlier work (Nakazaki et al., 2008) . Sox9-luciferase and its mutant constructs are described in Kanai and Koopman (1999) . Each of these constructs (0.2 µg) were transiently co-transfected into DAOY cells with Pax3-pcDNA3 or pcDNA3 vector control and Flag-Smad3 wild type (0.2 µg) or dominant negative Flag-DN-Smad3 (0.2 µg) cloned in HSV-TK-pEXL vector (kindly provided by Dr. H. F. Lodish, MIT). DAOY cells were used to maintain consistency with previous experiments done in our laboratory (Mayanil et al., 2000; Nakazaki et al., 2008) . 24 hrs posttransfection, transfected DAOY cells were treated or not treated with 10ng/ml human recombinant TGFβ2 for 6 hrs. Luciferase activity was measured 48 hrs post-transfection using the Dual Luciferase Kit from Promega, as previously described (Mayanil et al., 2006) . Transfected cells not treated with TGFβ2 served as the negative control.
Comparison of common downstream genes regulated by Pax3 or TGFβ β β β β2
Microarray data from Mayanil et al. (2001) and Zavadil et al. (2001) were compared. Examination of 270 genes altered by Pax3, as examined in Pax3 stably transfected DAOY cells (Mayanil et al., 2001) , and 728 genes, in HaCaT keratinocytes, altered by 2 to 4 hour treatment with TGFβ (Zavadil et al., 2001) , yielded 58 genes that were altered in both studies. To increase stringency 2 fold or higher increase or decrease in expression levels was used as a cut off. This resulted in a total of 22 genes altered by both Pax3 overexpression and TGFβ treatment. From these 22, 10 candidate genes, 5 up-regulated and 5 down-regulated by Pax3 (Mayanil et al., 2001 ) and oppositely regulated by TGFβ treatment (Zavadil et al., 2001 ) are shown in Table 2 . Out of these 10 genes, we used three for our in situ hybridization and promoter-luciferase studies. Several genes not listed in Table 2 did show up-regulation or down-regulation in response to both Pax3 overexpression and TGFβ treatment. Kiwanis (CSKM and DGM) . The earlier preliminary part of the work described in this paper was done in the Neurobiology Program at Childrens Memorial Research Center, Chicago, IL 60614. 
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